CSIMarket


Trinity Biotech Plc  (TRIB)
Other Ticker:  
 


 

Trinity Biotech Plc

TRIB's Financial Statements and Analysis



Trinity Biotech Plc increased forth quarter of 2023 net loss per share of $-3.14 compare to net loss per share of $-1.22 recorded in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.


forth quarter of 2023
Earnings Per Share Revenues
$ -3.14 $  57 Mill
$-1.92     $-18M     -24 %



Trinity Biotech Plc's Revenue fell by -24 % in forth quarter of 2023 (Dec 31 2023) year on year, to $57 million and advanced by sequentially.


Trinity Biotech Plc is

More on TRIB's Income Statement



Trinity Biotech Plc in the forth quarter of 2023 recorded net loss of $-36.868 million, an improvement compare to net loss of $-41.002 million in IV. Quarter a year ago.

Sequentially company realized a net loss, compared to net income of $0.000 million in the previous quarter.

More on TRIB's Growth

Trinity Biotech Plc Inventories
In Dec 31 2023 company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -1.101-27.07%, to $-1 millions compare to same quarter a year ago

More on TRIB's Cash flow Statement


Trinity Biotech Plc does not pay out common stock dividend.

In trailing twelve-month period Trinity Biotech Plc payed $ -3.06 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -3.13 per share from $ -3.13.

Company repurchased 0.00 million shares or 0.00 % in Dec 31 2023.


More on TRIB's Dividends

 Market Capitalization (Millions) 12
 Shares Outstanding (Millions) 8
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -37
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 569




Trinity Biotech Plc does not pay out common stock dividend.

In trailing twelve-month period Trinity Biotech Plc had negative $ -3.06 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -3.13 per share from $ -3.13.

Company repurchased 0.00 million shares or 0.00 % in Dec 31 2023.


More on TRIB's Balance Sheets

 Market Capitalization (Millions) 12
 Shares Outstanding (Millions) 8
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -37
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 569
   


  News about Trinity Biotech Plc Earnings